Rockefeller Capital Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,157
| Closed | -$86.8K | – | 1505 |
|
|
2023
Q2 | $86.8K | Hold |
2,157
| – | – | ﹤0.01% | 1785 |
|
|
2023
Q1 | $156K | Hold |
2,157
| – | – | ﹤0.01% | 1856 |
|
|
2022
Q4 | $176K | Hold |
2,157
| – | – | ﹤0.01% | 1721 |
|
|
2022
Q3 | $203K | Buy |
2,157
+420
| +24% | +$39.5K | ﹤0.01% | 1645 |
|
|
2022
Q2 | $338K | Buy |
1,737
+200
| +13% | +$38.9K | ﹤0.01% | 1427 |
|
|
2022
Q1 | $356K | Sell |
1,537
-20
| -1% | -$4.63K | ﹤0.01% | 1457 |
|
|
2021
Q4 | $613K | Buy |
1,557
+37
| +2% | +$14.6K | ﹤0.01% | 1245 |
|
|
2021
Q3 | $680K | Buy |
1,520
+590
| +63% | +$264K | ﹤0.01% | 1147 |
|
|
2021
Q2 | $361K | Sell |
930
-300
| -24% | -$116K | ﹤0.01% | 1318 |
|
|
2021
Q1 | $441K | Buy |
1,230
+330
| +37% | +$118K | ﹤0.01% | 1060 |
|
|
2020
Q4 | $441K | Hold |
900
| – | – | ﹤0.01% | 952 |
|
|
2020
Q3 | $291K | Buy |
+900
| New | +$291K | ﹤0.01% | 937 |
|